Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Result of DTPA Chelation for Gadolinium Deposition Disease

NCT06269055 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT06269055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06269055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Result of DTPA Chelation for Gadolinium Deposition Disease
Lead sponsor
Stanford University
Phase
Observational
Overall status
Completed
Start date
December 2, 2024
Completion date
November 23, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ca-dtpa, gadolinium deposition disease